Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415934 · ClinicalTrials.gov registry record · NA
Statin Discontinuation in Advanced Illness
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 381
- Enrollment target
NCT01415934 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 381 participants.
The verdict
NCT01415934, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 381 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there is a difference in survival rate at 60 days after enrollment between patients with advanced life-limiting illness for whom statins are discontinued vs. for patients with advanced life-limiting illness who are maintained on the medication. Secondary outcomes of this study will determine the effects of medication cessation on overall survival, important cardiovascular events, quality of life (QOL), symptoms, performance status, polypharmacy issues, satisfaction with care, and costs.
Interventions
- OTHER discontinue statins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 2011-06-03 |
| Est. Completion | 2013-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01415934
The ClinicalTrials.gov registry entry for NCT01415934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 381 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which discontinue statins is the first listed.
NCT01415934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01415934 about?
NCT01415934 is a clinical study titled "Statin Discontinuation in Advanced Illness". The purpose of this study is to determine if there is a difference in survival rate at 60 days after enrollment between patients with advanced life-limiting illness for whom statins are discontinued vs. for patients with advanced life-limiting illness who are maintained on the medication. Secondary ...
What is the current status of trial NCT01415934?
This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2011-06-03. Estimated completion is 2013-07-15.
What interventions are being tested in trial NCT01415934?
The interventions under investigation include: discontinue statins (OTHER).
Who is sponsoring clinical trial NCT01415934?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.